| 5/22/26 |
Roche (RO) |
giredestrant for Breast Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 5/22/26 |
Roche (RO) |
giredestrant for HR+/HER2- Breast Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 5/21/26 |
Rigel Pharmaceuticals (RIGL) |
Gavreto for Non-Small Cell Lung Cancer (NSCLC) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 5/21/26 |
Merck KGaA (MKKGY) |
Bavencio for Neuroendocrine Tumors (NET) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 5/21/26 |
Merck KGaA (MKKGY) |
Bavencio for Colorectal Cancer (CRC) |
Subscribers Only |
Subscribers Only |
Subscribers Only |